Anderson, I. M. (2000) ‘Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability', J Affect Disord, 58, pp.19-36.

British National formulary (2006). ‘Central nervous system: Antidepressant drugs' in BNF-.52. London: BMJ Publication group and RPS Publicaton.pp.198-208.

Bech, P., Cialdella, P., Haugh, M., Birkett, M. A., Hours, A., Boissel, P., Tollefson. (2000). ‘Meta- analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short term treatment of major depression', British J. of Psychiatry, 171, pp.421-428.

Department of Health (2007), ‘Basic prices of drugs, Part VIII', Drug Tariff, London, pp.69-132.

Department of Health, UK, Pharmacies and Prescriptions available at (accessed 15.1.07)

Finley, P.R. (2004 ) ‘Mood disorders I: major depressive disorders' in Kimble, M.A.K.,Young, L.Y., Kradjan, W.A,Guglielmo, B.J., Alldraedge, B.K, Corelli, R.L., (eds). Applied therapeutics the clinical use of drugs.8th ed. Lippincott Williams & Wilkins. pp. 79.1-79.37.

Food and Drug Administration.FDA statement on recommendation of the Psychopharmacologic Drugs and Pediatric Advisory Commeittees. available at (Accessed 09.1.07)

Furukawa T, Mcguir H, Barbui C, 2002. Meta-analysis of side effects of low dosage tricyclic antedepressantsin depression: a systemic review. Br Med J, volume 325.p.991

Grunebaum M F, Ellis S P, Li S,Oquendo M A& Mann J J .2004.Antidepressants and suicide risks in the United States, 1985- 1999. J Clin Psychiatry. Volume 65:11. p.1456-1462

Gunnel D, Saperia D &Ashby D. 2005,Selective serotonin re-uptake inhibitors (SSRIs) and suicide in adults:meta-analysis of drug company data from placebo controlled, randomilised controlled trails submitted to the MHRA's safety review.Br Med J,volume 330.p.385

Hamre H., Witt C M , Glockmann A, Giegler R, Willich S N ,Kiene H.2006 . Anthroposophic treatment for chronic depression: a four year prospective cohort study. BMC Psychiatry.p.6:57

Isacsson G, Holmgren P & Ahlner J.2005. Selective serotonin re-uptake inhibitors antidepressants and the risk of suicide: a controlled forensic database study of 14857 suicides. Acta Psychiatr Scand.volume 111.p.286-290.

Katon W, Unutzer J, Fan M Y, Williams J W, Schoenbaum M, Lin E H B and Hunkeler E M. 2006. Cost effectiveness and net benefit of enhanced treatment of depression for older adults with diabetics and depression. Diabetic care, volume 29; 265 -269.

Maa J, Lee K V& Stafford R S.2005.Depression treatment during outpatients visits by children and adolescents.J of Adolescent Health.vol 37.p.434-442.

MacGillivray S, Arroll B,Hatcher S,Ogston S, Sullivan F, Williams B& Crombie I.2003,Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systemic review and meta-analysis. Br Med J,volume 326.p.1014-1019

MHRA reports.Commeitee on safety of medicines' expert working group. Report of the CSM Expert working group on safety of Selective serotonin reuptake inhibitors antidepressants. Available at (accessed 11.3.07)

National institute of clinical excellence, NICE,UK, Costing clinical guidelines: depression (England and Wales) , 2004 available at (accessed 20.1.07)

National institute of clinical excellence, NICE, UK, Costing Template. Depression in children and young people: Identification and management in primary, community and secondary care, 2005. available at template/pdf/english (accessed 24.1.07)

National institute of clinical excellence, NICE, UK, Depression in children and young people: Identification and management in primary, community and secondary care, 2005. available at (accessed 20.1.07)

National institute of clinical excellence, NICE,UK,Depression: Management of depression in primary and secondary care,2004 available at (accessed 07.1.07)

National library for Health, NHS ,Clinical knowledge summaries, Depression.2005 Available at /pils/depression.pdf (accessed 15.1.07)

Panzarino P J and Nash D B, 2001. Cost-effective Treatment of depression with selective serotonin reuptake inhibitors. Am J Manng Care; 7: 173-184.

Pirraglia P A, Rosen A, Hermann R, Olchanski N V, and Neumann P,2006, Cost- Utility Analysis studies of depression management: A Systematic Review. Am J Psychiatry, 161:12, 2155-2160.

Pratt P.Affective disorders.In:Walker R, Edwards C, editors, 2003.Clinical pharmacy and therapepeutics.3rd ed.Churchill Livingstone;p.439-454

Peveler R, Kendrick T, Buxton M, Longworth L, Baldwin D,Moore M, Chatwin J,Goddard J, Thornet A, Smith H, Cambell M and Thompson C. 2005.A randomised control trial to compare the cost effectiveness of tricyclic antidepressants ,selective serotonin reuptake inhibitors and lofepramine. Health Technology Assessement, vol 9, No 16

Rost K, Nutting P, Smith J, Elliott C E, Dickinson M, 2002, Managing depression as a chronic disease: a randomised trial of ongoing treatment in primary care. Br Med J;325;934

Scott J, Palmer S, Paykel E, Teasdale J and Hayhurst H, 2003. Use of cognitive therapy for relapse prevention in chronic depression: cost effectiveness study. BJ Psychiatry;182,221-227

Simpson S, Corney R, Fitzerald R and Beecham J. 2000.A randomised control trial to evaluate the effectiveness and cost effectiveness of councelling patients with chronic depression. Health Technology Assessement, vol:no 36

Spigset O and Martensson B. Fortnighty review: Drug treatment of depression. BMJ; 1999: 1188-1191

Tiihonem J,Lonnqvist J, Wahlbeck K,Klaukka T, Tanskanen A& Haukka J.2006.Antidepressants and the risk of the Suicide, Attempted suicide, and Overall Mortality in a Nationwide Cohort.Arch.Gen.Psychiatry.volume 63.p.1358-1367.

Please be aware that the free essay that you were just reading was not written by us. This essay, and all of the others available to view on the website, were provided to us by students in exchange for services that we offer. This relationship helps our students to get an even better deal while also contributing to the biggest free essay resource in the UK!